Geode Capital Management’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
596,018
-18,505
| -3% | -$403K | ﹤0.01% | 2183 |
|
|
2025
Q1 | $11.4M | Buy |
614,523
+18,341
| +3% | +$339K | ﹤0.01% | 2209 |
|
|
2024
Q4 | $15.9M | Sell |
596,182
-983
| -0.2% | -$26.2K | ﹤0.01% | 2083 |
|
|
2024
Q3 | $14M | Buy |
597,165
+362,221
| +154% | +$8.51M | ﹤0.01% | 2174 |
|
|
2024
Q2 | $4.36M | Buy |
234,944
+9,895
| +4% | +$184K | ﹤0.01% | 2814 |
|
|
2024
Q1 | $4.02M | Buy |
+225,049
| New | +$4.02M | ﹤0.01% | 2814 |
|